Pain,
Год журнала:
2021,
Номер
163(3), С. 508 - 517
Опубликована: Июнь 17, 2021
Abstract
Opioids
are
the
frontline
analgesics
in
pain
management.
However,
chronic
use
of
opioid
causes
paradoxical
that
contributes
to
decrease
their
efficacy
control
and
escalation
dose
long-term
management
pain.
The
underling
pathogenic
mechanism
is
not
well
understood.
Microglia
have
been
commonly
believed
play
a
critical
role
expression
opioid-induced
hyperalgesia
animal
models.
We
performed
microglial
ablation
experiments
using
either
genetic
(CD11b-diphtheria
toxin
receptor
transgenic
mouse)
or
pharmacological
(colony-stimulating
factor-1
inhibitor
PLX5622)
approaches.
Surprisingly,
ablating
microglia
these
specific
effective
approaches
did
cause
detectable
impairment
induced
by
morphine.
confirmed
this
conclusion
with
behavioral
test
mechanical
thermal
hyperalgesia,
male
female
mice,
different
species
(mouse
rat).
These
findings
raise
caution
about
widely
assumed
contribution
development
hyperalgesia.
Frontiers in Pain Research,
Год журнала:
2021,
Номер
2
Опубликована: Авг. 25, 2021
Intractable
neuropathic
pain
is
a
frequent
consequence
of
nerve
injury
or
disease.
When
peripheral
nerves
are
injured,
damaged
axons
undergo
Wallerian
degeneration.
Schwann
cells,
mast
fibroblasts,
keratinocytes
and
epithelial
cells
activated
leading
to
the
generation
an
"inflammatory
soup"
containing
cytokines,
chemokines
growth
factors.
These
primary
mediators
sensitize
sensory
endings,
attract
macrophages,
neutrophils
lymphocytes,
alter
gene
expression,
promote
post-translational
modification
proteins,
ion
channel
function
in
afferent
neurons.
This
leads
increased
excitability
spontaneous
activity
secondary
including
colony
stimulating
factor
1
(CSF-1),
chemokine
C-C
motif
ligand
21
(CCL-21),
Wnt3a,
Wnt5a.
Release
these
from
neurons
alters
properties
spinal
microglial
causing
them
release
tertiary
mediators,
many
situations
Frontiers in Pain Research,
Год журнала:
2023,
Номер
4
Опубликована: Сен. 22, 2023
Neuropathic
pain
can
result
from
injury
to,
or
disease
of
the
nervous
system.
It
is
notoriously
difficult
to
treat.
Peripheral
nerve
promotes
Schwann
cell
activation
and
invasion
immunocompetent
cells
into
site
injury,
spinal
cord
higher
sensory
structures
such
as
thalamus
cingulate
cortices.
Various
cytokines,
chemokines,
growth
factors,
monoamines
neuropeptides
effect
two-way
signalling
between
neurons,
glia
immune
cells.
This
sustained
hyperexcitability
spontaneous
activity
in
primary
afferents
that
crucial
for
onset
persistence
well
misprocessing
information
supraspinal
structures.
Much
current
understanding
aetiology
identification
drug
targets
derives
studies
consequences
peripheral
rodent
models.
Although
a
vast
amount
has
been
forthcoming,
translation
this
clinical
arena
minimal.
Few,
if
any,
major
therapeutic
approaches
have
appeared
since
mid
1990's.
may
reflect
failure
recognise
differences
processing
males
vs.
females,
cellular
responses
different
types
humans
animals.
Basic
science
which
seek
bridge
knowledge
gap
include
better
assessment
animal
models,
use
models
emulate
human
disease,
stratification
phenotypes
according
quantitative
signs
symptoms
disease.
lead
more
personalized
effective
treatments
individual
patients.
Significance
statement:
There
an
urgent
need
find
new
neuropathic
pain.
classical
revealed
essential
features
central
sensitization
some
molecular
mechanisms
involved,
they
do
not
adequately
model
multiplicity
states
injuries
bring
forth
clinic.
review
seeks
integrate
disciplines
understand
pain;
including
immunology,
biology,
electrophysiology
biophysics,
anatomy,
neurology,
pharmacology
behavioral
science.
Beyond
this,
it
underlines
ongoing
refinements
basic
practice
will
engender
improved
management.
Abstract
Despite
the
success
of
combination
antiretroviral
therapy
(ART)
for
individuals
living
with
HIV,
mild
forms
HIV-associated
neurocognitive
disorder
(HAND)
continue
to
occur.
Brain
microglia
form
principal
target
HIV
infection
in
brain.
It
remains
unknown
how
these
cells
leads
neuroinflammation,
neuronal
dysfunction,
and/or
death
observed
HAND.
Utilizing
two
different
inducible
pluripotent
stem
cell-derived
brain
organoid
models
(cerebral
and
choroid
plexus
[ChP]
organoids)
containing
microglia,
we
investigated
pathogenic
changes
associated
infection.
Infection
was
a
sharp
increase
CCL2
CXCL10
chemokine
gene
expression
activation
many
type
I
interferon
stimulated
genes
(MX1,
ISG15,
ISG20,
IFI27,
IFITM3
others).
Production
proinflammatory
chemokines
persisted
at
low
levels
after
treatment
cell
cultures
ART,
consistent
persistence
HAND
following
clinical
introduction
ART.
Expression
multiple
members
S100
family
inflammatory
sharply
increased
measured
by
single-cell
RNA-seq.
However,
not
limited
but
also
detected
more
broadly
uninfected
stromal
cells,
mature
immature
ChP
neural
progenitor
importantly
bystander
neurons
suggesting
propagation
response
cells.
Neurotransmitter
transporter
declined
neurons,
accompanied
promoting
cellular
senescence
death.
Together,
studies
underscore
an
generated
HIV-infected
is
propagated
ultimately
resulting
dysfunction
neurons.
Frontiers in Aging Neuroscience,
Год журнала:
2020,
Номер
12
Опубликована: Май 14, 2020
Alzheimer's
disease
(AD)
has
been
a
major
health
issue
for
more
than
one
century
since
it
was
first
reported
in
1906.
As
of
the
most
common
neurodegenerative
diseases,
AD
is
characterized
by
presence
senile
plaques
and
neurofibrillary
tangles
(NFTs)
affected
brain
area.
Microglia
are
regulator
neuroinflammation
brain,
core
pathophysiological
process
various
diseases.
In
central
nervous
system
(CNS),
microglia
play
dual
role
development.
For
thing,
they
degrade
amyloid
β
(Aβ)
to
resist
its
deposition;
another,
release
pro-inflammatory
inflammatory
factors,
contribute
as
well
spreading
Aβ
tau
pathology.
Wnt
pathways
important
regulators
cell
fate
activities.
The
dysregulation
responsible
both
abnormal
phosphorylation
synaptic
loss
AD.
Recent
studies
have
also
confirmed
regulatory
effect
signaling
on
microglial
inflammation.
Thus,
microglia,
their
possible
interactions
may
open
up
new
direction
underlying
mechanisms
this
review,
we
summarize
function
pathways,
roles
order
provide
ideas
understanding
pathogenesis
iScience,
Год журнала:
2021,
Номер
24(3), С. 102186 - 102186
Опубликована: Фев. 16, 2021
Microglia
are
ubiquitous
central
nervous
system
(CNS)-resident
macrophages
that
maintain
homeostasis
of
neural
tissues
and
protect
them
from
pathogen
attacks.
Yet,
their
differentiation
in
different
compartments
remains
elusive.
We
performed
single-cell
RNA-seq
to
compare
microglial
subtypes
the
cortex
spinal
cord.
A
multi-way
comparative
analysis
was
carried
out
on
samples
C57/BL
HIV
gp120
transgenic
mice
at
two,
four,
eight
months
age.
The
results
revealed
overlapping
but
distinct
populations
differential
heterogeneity
microglia
these
CNS
regions
further
suggested
by
disparity
plasticity
response
life
span
progression
HIV-1
pathogenic
protein
gp120.
Our
findings
indicate
adapted
local
environments
fulfill
region-specific
biological
functions.
Viruses,
Год журнала:
2025,
Номер
17(2), С. 203 - 203
Опубликована: Янв. 31, 2025
Neurological
disorders,
some
of
which
are
associated
with
viral
infections,
growing
due
to
the
aging
and
expanding
population.
Despite
strong
defenses
central
nervous
system,
viruses
have
evolved
ways
breach
them,
often
result
in
dire
consequences.
In
this
review,
we
recount
various
by
different
can
enter
CNS,
describe
consequences
such
invasions.
Consequences
may
manifest
as
acute
disease,
encephalitis,
meningitis,
or
long-term
effects,
neuromuscular
dysfunction,
occurs
poliomyelitis.
We
discuss
evidence
for
involvement
causation
well-known
chronic
neurodegenerative
diseases,
Alzheimer's
Parkinson's
amyotrophic
lateral
sclerosis,
multiple
well
vascular
dementia
elderly.
also
approaches
currently
available
control
a
few
neural
infections.
These
include
antivirals
that
effective
against
human
immunodeficiency
virus
herpes
simplex
virus,
vaccines
valuable
controlling
rabies
poliomyelitis
flavivirus
There
is
an
urgent
need
better
understand,
at
molecular
level,
how
contribute
and,
especially,
neurological
diseases
develop
more
precise
therapies.
Research Square (Research Square),
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 1, 2025
Background:
Pathological
inflammation
with
a
loss
of
synaptic
integrity
and
function
has
been
implicated
in
HIV
Associated
Neurocognitive
Disorders
(HAND).
Although
therapeutics
exist
to
increase
the
lifespan
people
living
(PLWH),
they
are
not
effective
at
preventing
neuroinflammation
induced
neuronal
damage
persists.
In
this
study,
we
investigate
ephrin-B/EphB
axis,
which
regulates
inflammation,
post-mortem
brain
specimen
PLWH
experimental
models
order
assess
its
potential
role
neuroinflammation.
Methods:
We
analyze
mRNA
samples
uninfected
controls
obtained
from
National
NeuroAIDS
Tissue
Consortium
(NNTC)
and,
for
comparison,
transgenic
mouse
model
neuroHIV
using
quantitative
reverse
transcription
polymerase
chain
reaction
(qRT-PCR).
Follow-up
experiments
employ
tissue
vitro
models,
including
immortalized
human
microglia,
pluripotent
stem
cell
(iPSC)-derived
mixed
neuroglial
cultures,
cellular
molecular
interference,
functional
multiplex
assays,
immunofluorescence
sequencing
examine
axis
associated
neurotoxicity.
Results:
Using
qRT-PCR
find
increased
expression
EphB2
PLWH,
detect
correlation
pro-viral
DNA,
viral
RNA
an
inverse
abstract
executive
verbal
fluency.
Increased
protein
level
is
also
observed
brains
suggesting
upregulation
can
be
driven,
least
part,
by
gp120
envelope
type
I
interferon,
IFNβ.
Additionally,
induction
ephrin-B1
microglia
following
activation
Given
previously
reported
impact
on
periphery,
EphB2-mediated
ephrin-B
signaling
assessed
pro-inflammatory
anti-viral
signature.
that
treated
secrete
inflammatory
factors
but
exert
contact-independent
Finally,
knockdown
microglial
ephrin-B1,
binding
partner,
shows
partial
alleviation
signature
Conclusion:
Our
study
suggests
elevated
EphB2,
through
contribute
neurotoxicity
neuroHIV.
Frontiers in Pharmacology,
Год журнала:
2021,
Номер
12
Опубликована: Апрель 20, 2021
In
the
management
of
human
immunodeficiency
virus
(HIV)
infection
around
world,
chronic
complications
are
becoming
a
new
problem
along
with
prolonged
life
expectancy.
Chronic
pain
is
widespread
in
HIV
infected
patients
and
even
affects
those
low
viral
load
undergoing
long-term
treatment
antiviral
drugs,
negatively
influencing
adherence
to
disease
quality
life.
A
large
proportion
neuropathic
pain,
which
defined
as
caused
by
nervous
system
lesions
or
diseases,
presenting
series
symptoms
including
both
positive
negative
signs.
Injury
protein,
central
peripheral
sensitization,
side
effects
antiretroviral
therapy
lead
neuroinflammation,
regarded
maladaptive
mechanism
originally
serving
promote
regeneration
healing,
constituting
main
HIV-related
pain.
Gp120,
envelope
has
been
found
be
major
toxin
that
induces
Particularly,
microglia,
releasing
numerous
pro-inflammatory
substances
(such
TNFα,
IL-1β,
IL-6),
not
only
sensitize
neurons
but
also
center
part
crosstalk
bridging
astrocytes
oligodendrocytes
together
forming
sensitization
during
infection,
discussed
detailly
recent
reviews.
meantime,
some
NRTIs
PIs
exacerbate
neuroinflammation
response.
this
review,
we
highlight
importance
clarifying
discuss
about
limitation
related
studies
future
research
directions.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(9), С. 4697 - 4697
Опубликована: Апрель 25, 2024
Despite
combined
antiretroviral
therapy
(cART)
limiting
HIV
replication
to
undetectable
levels
in
the
blood,
people
living
with
continue
experience
HIV-associated
neurocognitive
disorder
(HAND).
HAND
is
associated
impairment,
including
motor
and
memory
loss.
has
been
detected
brain
within
8
days
of
estimated
exposure
mechanisms
for
this
early
entry
are
being
actively
studied.
Once
having
entered
into
central
nervous
system
(CNS),
degrades
blood-brain
barrier
through
production
its
gp120
Tat
proteins.
These
proteins
directly
toxic
endothelial
cells
neurons,
propagate
inflammatory
cytokines
by
activation
immune
dysregulation
tight
junction
The
BBB
breakdown
progression
disease.
One
main
hurdles
treatment
latent
pool
cells,
which
insensitive
cART
prolong
inflammation
harboring
provirus
long-lived
that
can
reactivate,
causing
damage.
Multiple
strategies
studied
combat
HAND;
however,
clinically,
these
approaches
have
insufficient
require
further
revisions.
goal
paper
aggregate
known
challenges
HAND.